Dosimetric effects of embolization material artefacts in arteriovenous malformations stereotactic radiosurgery on treatment planning calculation. (July 2022)

• Record Type: Journal Article
• Authors: Elawadi, Abousaleh; Alshanqity, Mukhtar; AlHussain, Hussain; Mohamed, Reham; Orz, Yasser; Alqahtani, Sultan; Melheim, Sayel
• Is Part Of: Physics and imaging in radiation oncology. Volume 23(2022)
• Page Start: 60
• Page End: 65
• Publication Date: 2022-07
• Subjects: Embolic materials -- Stereotactic radiosurgery -- Arteriovenous malformations; Radiotherapy -- Periodicals; Radiation dosimetry -- Periodicals; Cancer -- Imaging -- Periodicals; Oncology -- Periodicals; 615.842
• DOI: 10.1016/j.phro.2022.06.014
• Languages: English
• ISSNs: 2405-6316

Abstract

Abstract: Background and Purpose: Stereotactic Radiosurgery (SRS) is a specialized radiotherapy treatment technique for Arteriovenous Malformations (AVM) in which Computed Tomography (CT) images are used for dose calculations. The purpose of this study was to investigate CT image distortions caused by embolic agents and quantify the influence of these distortions on dose calculations. Methods: Eight AVM patients administered embolic agents prior to SRS were included. Original plans were compared to new recalculated plans using two sets of images. The first set was created by masking the embolic material and artefacts, the second was the diagnostic CT images. In addition, treatment plans were created for an anthropomorphic phantom with water inserts, then with known volumes of embolic materials to study the dosimetric effect of each material. Results: Relative to patients' original plans, maximum Monitor Unit (MU) difference was −4.4% with whole brain masking, −1.3% with artefact masking, −4.1% with embolic masking, and −4.5% with artefact-free diagnostic images. Calculated dose differences were within ± 3.5% for all plans. In phantom, Gamma pass rate was 96% for both embolic agents with conformal fields and 99.9% with dynamic arcs. Dose and MU differences in phantom plans were negligible. Conclusion: Relative dose differences between the original plans and the corrected ones were not clinically remarkable. We recommend evaluating the effect of embolic materials on individual patients' plans. The whole brain corrected planning CT images or diagnostic CT images could be utilized to calculate the magnitude of dose reduction caused by embolic materials and correct it if necessary.